Skip to main content
Log in

Gastric functions in portal hypertension

Role of endothelin

  • Liver: Cirrhosis, Fibrosis, Portal Hypertension, And Transplantation
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

This study investigated the effects of portal hypertension on gastric motor and secretory functions and the role of endothelin in rats. Control; sham-operated; endothelin-A receptor blocker, BQ 485 (1 µg/kg) -treated; portal hypertensive; and portal hypertension +, endothelin-A receptor blocker-treated rats were subjected to tests of gastric secretory, motor, and mucosal function studies as well as gastric wall polymorphonuclear infiltration. Portal hypertension was induced by partial portal vein ligation. Portal hypertension suppressed gastric acid and total fluid secretion and delayed gastric emptying. An increase in mucosal permeability and no alteration in gastric wall myeloperoxydase activity were observed. The effects of portal hypertension on gastric secretory, motor, and mucosal functions were reversed by treatment with endothelin-A receptor blocker, BQ-485. It is concluded that portal hypertension suppresses the gastric motor and secretory functions and endothelin plays an important role in the pathophysiology of gastric alterations associated with portal hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Baxter JN, Dobbs BR: Portal hypertensive gastropathy. J Gastroenterol Hepatol 3:635–644, 1988

    Google Scholar 

  2. Dobbs BR, Hider RN, Baxter JN: Structural and functional changes of the gastric mucosa in rats with portal hypertension. J Gastroenterol Hepatol 6:350–354, 1991

    Google Scholar 

  3. Ma JJ, Cho CH, Ogle CW: Portal hypertension. Its effects on gastric function and ethanol-induced gastric mucosal damage in rats. Dig Dis Sci 38:2203–2208, 1993

    Google Scholar 

  4. Sherlock S: Hepatic cirrhosis.In Diseases of the Liver and Biliary System, 8th ed. Oxford, Blackwell Scientific Publications, 1989, pp 410–424

    Google Scholar 

  5. Chesta J, Lillo R, Defilippi C, Velasco M, Katz R: Orocecal transit time and gastric emptying in patients with cirrhosis. Gastroenterology 100:A43, 1991

    Google Scholar 

  6. Yanagisawa M: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415, 1988

    Google Scholar 

  7. Takahashi K, Jones PM, Kanse SM, Lam HC, Spokes RA, Ghatei MA, Bloom SR: Endothelin in the gastrointestinal tract. Presence of endothelin-like immunoreactivity, messenger RNA, endothelin receptors, and pharmacological effect. Gastroenterology 99:1660–1667, 1990

    Google Scholar 

  8. Kitsukawa Y, Gu ZF, Hildebrand P, Jensen RT: Gastric smooth muscle cells possess two classes of endothelin receptors but only one alters contractions. Am J Physiol 66:G713-G721, 1994

    Google Scholar 

  9. Inagashi H, Bishop AE, Escrig C, Wharton J, Allen-Mersh TG, Polak JM: Localisation of endothelin-like immunoreactivity and endothelin binding sites in human colon. Gastroenterology 101:47–54, 1991

    Google Scholar 

  10. Yoshinaga M, Chijiwa Y, Misawa T, Harada NN, Nawata H: Endothelin-B receptor on guinea pig small intestinal smooth muscle cells. Am J Physiol 262:G308-G311, 1992

    Google Scholar 

  11. Uchihara M, Izumi N, Sato C, Marumo F: Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Hepatology 16:95–99, 1992

    Google Scholar 

  12. Asbert M, Gines A, Gines P, Jimenes W, Claria J, Salo J, Arroyo V, Francisca R, Rodes J: Circulating levels of endothelin in cirrhosis. Gastroenterology 104:1485–1491, 1993

    Google Scholar 

  13. Yu PC, Kuo JS, Lin HC, Yang MCM: Effects of endothelin in portal hypertensive rats. Clin Sci 83:165–170, 1992

    Google Scholar 

  14. Isobe H, Sakai H, Satoh M, Sakamoto S, Nawata H: Delayed gastric emptying in patients with liver cirrhosis. Dig Dis Sci 39:983–987, 1994

    Google Scholar 

  15. Galati JS, Holdeman KP, Dalrymple GV, Harrison KA, Quigley EMM: Delayed gastric emptying in patients both liquid and solid components of a meal in chronic liver disease. Am J Gastroenterol 89:708–711, 1994

    Google Scholar 

  16. Scarpignato C, Capovilla T, Bertaccini G: Action on gastric emptying of conscious rat. Arch Int Pharmacodyn 246:286–294, 1980

    Google Scholar 

  17. Coşkun T, Sevinç A, Tevetoğlu İ, Alican İ, Kurtel H, Yeğen BÇ: Delayed gastric emptying in conscious male rats following estrogen and progesterone treatment. Res Exp Med 195:49–54, 1995

    Google Scholar 

  18. Wang WSF, Rahwan RG: Antiulcer activity of the calcium antagonist propymethylene-dioxyindene-11. Effects on acid secretion and gastric emptying in rats. Clin Pharmacol 21:327–331, 1990

    Google Scholar 

  19. Levine RL, Garland D, Oliver CN: Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–478, 1990

    Google Scholar 

  20. Suzuki K, Hiromo O, Sasgawa S, Sakatani T, Fujikara T: Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Ann Biochem 13:345–352, 1983

    Google Scholar 

  21. Tally NJ, Shuter B, McCrudden G, Jones M, Hoschl R, Piper DW: Lack of association between gastric emptying of solids and symptoms in nonulceer dyspepsia. J Clin Gastroenterol 11:625–630, 1989

    Google Scholar 

  22. Vorobioff J, Bredfeldt JE, Groszmann RJ: Hyperdynamic circulation in portal hypertensive rat model: A primary factor for maintenance of chronic portal hypertension. Am J Physiol 244:G52-G57, 1983

    Google Scholar 

  23. Benoit JN, Granger DN: Splanchnic hemodynamics in chronic portal hypertension. Semin Liver Dis 6:287–289, 1986

    Google Scholar 

  24. Beutler JJ, Koomans HA, Rabelink YJ: Blunted natriuretic response and low blood pressure after atrial natriuretic factor in early cirrhosis. Hepatology 10:148–153, 1989

    Google Scholar 

  25. Vallance P, Moncada S: Hyperdynamic circulation in cirrhosis: A role for nitric oxide? Lancet 337:776–778, 1991

    Google Scholar 

  26. Pizcueta MP, Casamitjana R, Bosh J, Rodes J: Decreased vascular sensitivity to norepinephrine in portal hypertensive rats: Role of hyperglucagonism. Am J Physiol 258:G191-G195, 1990

    Google Scholar 

  27. Itoh S, Sasaki T, Katsuhisa I, Ishikawa K, Nishikibe M, Yaro M: A novel endothelin ETA receptor antagonist, BQ 485, and its preservative effect in experimental cerebral vasospasm in dogs. Biochem Biophys Res Commun 195:969–975, 1993

    Google Scholar 

  28. Wallace JL, Giuseppe C, DeNucci G, McKnight W, Mac-Naughton WK: Endothelin has potent ulcerogenic and vasoconstrictor actions in the stomach. Am J Physiol 256:G661-G666, 1989

    Google Scholar 

  29. Wallace JL, Keenan CM, MacNaughton WK, McKnight GW: Comparison of the effects of endothelin 1 and endothelin 3 in the rat stomach. Eur J Pharmacol 167:41–47, 1989

    Google Scholar 

  30. Rubanyi GM, Polokoff MA: Endothelins: Molecular biology, biochemistry pharmacology, physiology and pathophysiology. Pharm Rev 46:325–415, 1994

    Google Scholar 

  31. Claria J, Jimenez W, Ros J: Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxide. Hepatology 15:343–349, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Günal, Ö., Yeğen, C., Özdemir Aktan, A. et al. Gastric functions in portal hypertension. Digest Dis Sci 41, 585–590 (1996). https://doi.org/10.1007/BF02282345

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02282345

Key words

Navigation